Clinical pharmaceutics and calcium-ceftriaxone.
Gin
Alfred S
AS
Wheaton
Hannah
H
Dalton
Bruce
B
D002118:Calcium / Q000009:adverse effects / Q000493:pharmacokinetics*; D002443:Ceftriaxone / Q000009:adverse effects / Q000493:pharmacokinetics*; D011232:Chemical Precipitation; D004347:Drug Interactions / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D020347:Lithiasis / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control; D012995:Solubility / Q000187:drug effects; D014481:United States; D014486:United States Food and Drug Administration
D002443:Ceftriaxone; D002118:Calcium